| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CONDUIT PHARMACEUTICALS INC. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 840,000 | $77,196 | $0.0919 | 18 Nov 2024 | Direct |
| CONDUIT PHARMACEUTICALS INC. | Chief Executive Officer, Director | Warrant (Right to buy) | 200,332 | 22 Apr 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CDT | CONDUIT PHARMACEUTICALS INC. | 18 Nov 2024 | 1 | +$77,196 | 4 | Chief Executive Officer, Director | 20 Nov 2024, 16:30 |
| CDT | CONDUIT PHARMACEUTICALS INC. | 22 Apr 2024 | 2 | $0 | 4 | Chief Executive Officer, Director | 24 Apr 2024, 17:00 |
| CDT | CONDUIT PHARMACEUTICALS INC. | 01 Dec 2023 | 1 | +$1,642,966 | 4 | Director | 05 Dec 2023, 17:20 |
| CDT | CONDUIT PHARMACEUTICALS INC. | 22 Sep 2023 | 0 | $0 | 3 | Chief Executive Officer, Director | 26 Sep 2023, 18:34 |